Sale is live|00:00:00
Vinati Organics LtdQ2 FY18

Vinati Organics Ltd

Q2 FY18 Earnings Call Analysis

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

No

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2
  • Vinati Organics expects overall sales growth at a CAGR of ~25% for the next 3 years.
  • ATBS volumes are projected to grow by 25%-30% annually for the next 2-3 years, driven by capacity expansion from 26,000 to 40,000 tonnes by April 2019.
  • Butylphenols plant to start by April 2019 with 60-65% capacity utilization in FY2020 and full utilization in FY2021, targeting Rs.350-400 Crores in sales.
  • IBB volumes expected to grow around 15% in FY2020 after subdued growth in FY2019 due to customer shutdown.
  • PAP project’s commercialization is uncertain; management excludes it from near-term projections.
  • Continued focus on new products backed by R&D pipeline to sustain long-term growth.

Margin guidance

Category 3
  • Vinati Organics expects profits to grow at 25%-30% annually over the next three years.
  • EBITDA margins are anticipated to sustain around 35%, supported by high-margin ATBS volumes and stable product mix.
  • The company projects a 25% volume growth in ATBS for the next two to three years due to increased capacity and market leadership.
  • Butylphenol plant commissioning in April 2019 will ramp up sales to Rs.350-400 Crores, achieving 60%-65% capacity utilization in FY2020 and full utilization by FY2021.
  • IBB volumes are expected to grow approximately 15% annually from FY2020, recovering from prior customer shutdowns and capacity expansion.
  • PAP project is uncertain; management advises excluding PAP from near-term projections.
  • Overall, business growth driven by existing products with new capacities and expansions support a robust earnings growth outlook.

Sign up free to read the full earnings analysis

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Vinati Organics Ltd and 1,400+ other companies.

Fundraise plans

No
  • Vinati Organics Limited does not plan to raise any debt for current or future projects.
  • All future projects, including the PAP project, are expected to be funded entirely through internal accruals.
  • The company currently has no debt on the books.
  • Management aims to maintain a payout ratio of about 20%, reinvesting most cash flows back into the business to maximize returns.
  • Cash flows for the current year are expected to be around Rs.400 Crores on Rs.1000 Crores revenues, indicating strong internal funding capability.

Order book

  • The transcript does not explicitly mention the current or expected order book or pending orders for Vinati Organics Limited.
  • However, the company has highlighted strong demand and capacity utilization:
  • - ATBS capacity is fully utilized at 26,000 tonnes with plans to expand to 40,000 tonnes by April 2019 due to strong market demand and exit of competitor Lubrizol.
  • - IBB capacity has been expanded from 16,000 to 25,000 tonnes, catering to growing demand.
  • - The butylphenol plant is expected to start by April 2019 with ramp-up over FY2020 and FY2021.
  • The company expects growth driven by volume growth in ATBS and new customer additions.
  • Capex plans include Rs. 75-80 Crores for ATBS expansion and Rs. 240 Crores for butylphenol plant.
  • No specific order book figures or pending order details were provided in the call.

Capex plans

Yes
  • **ATBS Capacity Expansion:** Increasing from 26,000 to 40,000 tonnes; capex of Rs. 75-80 Crores, expected completion by April 2019.
  • **Butylphenol Plant:** Investment of Rs. 240 Crores, expecting sales of Rs. 350-400 Crores; plant to come on stream by April 2019, ramping up to 65% utilization in first year and 100% subsequently.
  • **PAP Project:** Pilot plant with Rs. 20 Crores investment; commercial decision pending successful pilot trials over next 3-6 months; potential major future project with estimated Rs. 600 Crores capex, 1:1 asset turnover, and 20% EBITDA margins.
  • **Overall Capex Guidance:** Rs. 300 Crores for FY2019 mainly for butylphenols and ATBS expansion; FY2020 capex uncertain, dependent on PAP project.
  • **Funding:** All future projects to be funded through internal accruals without additional debt; payout ratio maintained around 20%.

How does Vinati Organics Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature
1Vinati Organics Ltd
Rev 2Mar 3

See full Chemicals & Petrochemicals sector rankings

Unlock with Pro

Want more stocks like Vinati Organics Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio